FCGR3A and acute myeloid leukemia: However, TriKEs composed of one scFv against CD16, another against CD33 and a human IL-15 crosslinker promote NK cell effector functions, and also increase NK cell expansion and persistence in vivo in mouse preclinical models of AML and ovarian cancer (184, 185).